Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury ; volume:23 ; number:1 ; day:15 ; month:8 ; year:2023 ; pages:1-12 ; date:12.2023
BMC neurology ; 23, Heft 1 (15.8.2023), 1-12, 12.2023
- Urheber
-
Hossain, Iftakher
Mohammadian, Mehrbod
Maanpää, Henna-Riikka
Takala, Riikka S. K.
Tenovuo, Olli
Gils, Mark van
Hutchinson, Peter
Menon, David K.
Newcombe, Virginia F.
Tallus, Jussi
Hirvonen, Jussi
Roine, Timo
Kurki, Timo
Blennow, Kaj
Zetterberg, Henrik
Posti, Jussi P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-023-03284-6
- URN
-
urn:nbn:de:101:1-2023110310262291468002
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hossain, Iftakher
- Mohammadian, Mehrbod
- Maanpää, Henna-Riikka
- Takala, Riikka S. K.
- Tenovuo, Olli
- Gils, Mark van
- Hutchinson, Peter
- Menon, David K.
- Newcombe, Virginia F.
- Tallus, Jussi
- Hirvonen, Jussi
- Roine, Timo
- Kurki, Timo
- Blennow, Kaj
- Zetterberg, Henrik
- Posti, Jussi P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease